Shares of Walgreens Boots Alliance (WBA 1.72%) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by 3:30 p.m. ET. That gain was still notable, since the broader markets were down significantly on the day.
News reports circulated with further details on a potential buyout of the company by private equity firm Sycamore Partners, which has been in talks to buy the troubled pharmacy since late 2024.
According to people familiar with the matter and reported in the Financial Times, Sycamore Partners is proposing to split Walgreens into three separate companies: the main Walgreens pharmacy in the U.S., the Boots pharmacy and chemist in the U.K., and specialty pharmaceutical unit Shields Health Solutions. Moreover, the sources said Sycamore appeared to have the necessary financing lined up.
Walgreens had spiked on rumors of a buyout in December, but shares have since retreated back to where they were prior to that news due to a lack of follow-through, compounded by recent market volatility. Usually, buyouts are made at a decent premium to the existing price of a stock, so the new details on Sycamore's plans today appear to have sparked a near-term rally.
It should also be noted the Financial Times piece said that talks could still fall apart, and it's usually not a great strategy to bet on a buyout that hasn't yet been announced. Therefore, interested investors should only get involved if one believes Walgreens' earnings declines may be stabilizing, and if you believe in the turnaround plan in progress under new CEO Tim Wentworth, who took over in late 2023.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。